| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $22.3M | — | +11.4% |
| SG&A Expense | $8.9M | — | +34.5% |
| Operating Income | -$31.2M | — | -17.2% |
| Pre-tax Income | -$29.8M | — | -21.0% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$29.8M | — | -20.9% |
| EPS (Basic) | $0.44 | — | -8.3% |
| EPS (Diluted) | $0.44 | — | -8.3% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.6M | -27.0% | -41.3% |
| Short-term Investments | $239.3M | +66.7% | +58.0% |
| Current Assets | $289.2M | +43.6% | +30.1% |
| Total Assets | $337.1M | +52.2% | +17.9% |
| Current Liabilities | $24.6M | -23.0% | +90.0% |
| Total Liabilities | $55.6M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$28.9M | — | -12.5% |
| Capital Expenditures | $153K | — | -48.8% |
| Investing Cash Flow | -$126.3M | — | -48.6% |
| Financing Cash Flow | $141.7M | — | — |
| Free Cash Flow | -$29.1M | — | -11.8% |
| +54.4% |
| Stockholders' Equity | $281.5M | +67.9% | +12.6% |